1. Home
  2. ANGI vs KURA Comparison

ANGI vs KURA Comparison

Compare ANGI & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGI
  • KURA
  • Stock Information
  • Founded
  • ANGI 1995
  • KURA 2014
  • Country
  • ANGI United States
  • KURA United States
  • Employees
  • ANGI N/A
  • KURA N/A
  • Industry
  • ANGI Advertising
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ANGI Consumer Discretionary
  • KURA Health Care
  • Exchange
  • ANGI Nasdaq
  • KURA Nasdaq
  • Market Cap
  • ANGI 566.2M
  • KURA 492.9M
  • IPO Year
  • ANGI 2017
  • KURA N/A
  • Fundamental
  • Price
  • ANGI $15.78
  • KURA $6.16
  • Analyst Decision
  • ANGI Buy
  • KURA Strong Buy
  • Analyst Count
  • ANGI 8
  • KURA 12
  • Target Price
  • ANGI $21.36
  • KURA $24.50
  • AVG Volume (30 Days)
  • ANGI 1.5M
  • KURA 1.2M
  • Earning Date
  • ANGI 05-06-2025
  • KURA 05-01-2025
  • Dividend Yield
  • ANGI N/A
  • KURA N/A
  • EPS Growth
  • ANGI N/A
  • KURA N/A
  • EPS
  • ANGI 1.03
  • KURA N/A
  • Revenue
  • ANGI $1,125,635,000.00
  • KURA $67,991,000.00
  • Revenue This Year
  • ANGI N/A
  • KURA $171.90
  • Revenue Next Year
  • ANGI $3.69
  • KURA $60.51
  • P/E Ratio
  • ANGI $15.17
  • KURA N/A
  • Revenue Growth
  • ANGI N/A
  • KURA N/A
  • 52 Week Low
  • ANGI $10.88
  • KURA $5.41
  • 52 Week High
  • ANGI $29.15
  • KURA $23.48
  • Technical
  • Relative Strength Index (RSI)
  • ANGI 56.13
  • KURA 47.97
  • Support Level
  • ANGI $15.46
  • KURA $5.56
  • Resistance Level
  • ANGI $16.45
  • KURA $5.84
  • Average True Range (ATR)
  • ANGI 0.58
  • KURA 0.34
  • MACD
  • ANGI -0.07
  • KURA -0.00
  • Stochastic Oscillator
  • ANGI 17.18
  • KURA 43.69

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

Share on Social Networks: